Pharmacodynamic Equivalence Study Of Orlistat Capsules 60 mg
NCT05076474
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
84
Enrollment
INDUSTRY
Sponsor class
Conditions
Bioequivalence
Interventions
DRUG:
Orlistat 60mg Cap
Sponsor
Shandong New Time Pharmaceutical Co., LTD